Medication info

Olimelen 9 Injection

Prescription medicationSolutionInjection
Ingredient · strength
L-Glutamic Acid›7.11gL-Leucine›9.87gL-Lysine Acetate›15.8gL-Methionine›7.11gL-Valine›9.11gL-Serine›5.62gL-Arginine›13.95gL-Aspartic Acid›4.12gL-Alanine›20.6gL-Isoleucine›7.11gL-Threonine›7.11gL-Tryptophan›2.37gL-Tyrosine›0.37gL-Phenylalanine›9.87gL-Proline›8.49gL-Histidine›8.49gSodium Glycerophosphate Hydrate›9.18gGlycine›9.87gSodium Acetate Hydrate›3.74gMagnesium Chloride Hydrate›2.03gPotassium Chloride›5.59gGlucose Monohydrate›302.5gCalcium Chloride Hydrate›1.29gPurified Olive Oil›160gRefined Soyabean Oil›40g
Manufacturer / importer
.
Appearance
A transparent plastic bag divided into three compartments by two membranes, where the amino acid solution and sugar solution are clear, colorless to pale yellow liquids, and the fat solution is a homogeneous milky liquid.
Packaging
1000ml (400ml amino acid solution, 400ml sugar solution, 200ml fat solution), 1500ml (600ml amino acid solution, 600ml sugar solution, 300ml fat solution), 2000ml (800ml amino acid solution, 800ml sugar solution, 400ml fat solution)
Approval status
Active

MFDS item code 201205378 · Approved 2012.06.05 · Insurance code 078200061,078200071,078200081

Summary

Main use
Improvement of nutritional status through intravenous nutritional support (fluids, electrolytes, amino acids, etc.)
Who receives it
Adults · Children
Adult administration
The dose and bag size are determined according to the patient's condition, energy expenditure, metabolic capacity, body weight, and additional calories or protein supplied orally or via the gastrointestinal tract. Micronutrients, vitamins, electrolytes, etc. may be added according to the patient's condition. The maximum daily doses stated below must not be exceeded. Because the composition of the multi-chamber bag is fixed, it may not be possible to meet all of the patient's nutritional requirements simultaneously. There may be clinical situations in which the patient requires amounts of nutrients different from those in the fixed composition of this drug. In such cases, all dose adjustments must take into account their effects on the administration of all other nutrient components of this drug. 1. Adults Recommended daily dose - 0.16 g-0.35 g of nitrogen per kg of body weight (1 g-2 g of amino acids per kg of body weight), depending on the patient's nutritional status and degree of catabolism - 20-40 kcal per kg of body weight as total calories - 20-40 mL per kg of body weight as the total volume administered, or 1-1.5 mL per kcal consumed Maximum daily dose - The maximum daily dose is 35 mL per kg of body weight (equivalent to 2.0 g of amino acids, 3.9 g of glucose, 1.4 g of fat, 1.2 mmol of sodium, and 1.1 mmol of potassium per kg of body weight) Infusion rate - The infusion rate should not exceed 1.8 mL/kg per hour (equivalent to 0.10 g/kg of amino acids, 0.19 g/kg of glucose, and 0.07 g/kg of fat per hour). 3. Method and duration of administration - Because of its high osmolarity, this drug should be infused only into a central vein. The recommended infusion duration is 12~24 hours. Intravenous nutrition may be continued as needed according to the patient's condition. - In general, gradually increase the infusion rate over the first hour after starting administration, adjusting it in consideration of the total volume, daily dose, and infusion time.
Child administration
2. Pediatric patients aged 2 years and older - Daily requirements for dosage, nitrogen, and calories decrease with increasing age. - In patients aged 2 to 11 years, the limiting factor for the daily dose is the magnesium concentration, and the limiting factor for the hourly rate is the glucose concentration. - In patients aged 12 to 18 years, the limiting factors for the daily dose are the amino acid and magnesium concentrations, and the limiting factor for the hourly rate is the amino acid concentration. - Usually, lower doses are started in young children and gradually increased to the maximum dose. 1) Pediatric patients aged 2 to 11 years Maximum daily dose - The maximum daily dose is 25 mL/kg body weight (equivalent to 1.4 g amino acids/kg body weight, 2.8 g glucose/kg body weight, 1.0 g fat/kg body weight, and a total of 26.8 kcal/kg body weight) Infusion rate - The infusion rate should not exceed 3.3 mL/kg/hour (equivalent to 0.19 g amino acids/kg/hour, 0.36 g glucose/kg/hour, and 0.13 g fat/kg/hour) 2) Pediatric patients aged 12 to 18 years Maximum daily dose - The maximum daily dose is 35 mL/kg body weight (equivalent to 2.0 g amino acids/kg body weight, 3.9 g glucose/kg body weight, 1.4 g fat/kg body weight, and a total of 37.5 kcal/kg body weight) Infusion rate - The infusion rate should not exceed 2.1 mL/kg/hour (equivalent to 0.12 g amino acids/kg/hour, 0.23 g glucose/kg/hour, and 0.08 g fat/kg/hour)

Ingredients

Importer
.

Efficacy & effects

Improvement of nutritional status through intravenous nutritional support (fluids, electrolytes, amino acids, etc.)

View approved original text

This medication is used to provide effective hydration, electrolytes, amino acids, and calories to children aged 2 years and older and adults who have inadequate or impossible nutritional intake through the oral or gastrointestinal route. It helps to improve the patient's nutritional status and provides necessary nutrients to aid health recovery. It is particularly suitable for cases where gastrointestinal function is limited and plays an important role in maintaining the body's balance. This treatment significantly aids in enhancing the patient's overall nutritional management.

How it is given

Adult administration

The dose and bag size are determined according to the patient's condition, energy expenditure, metabolic capacity, body weight, and additional calories or protein supplied orally or via the gastrointestinal tract. Micronutrients, vitamins, electrolytes, etc. may be added according to the patient's condition. The maximum daily doses stated below must not be exceeded. Because the composition of the multi-chamber bag is fixed, it may not be possible to meet all of the patient's nutritional requirements simultaneously. There may be clinical situations in which the patient requires amounts of nutrients different from those in the fixed composition of this drug. In such cases, all dose adjustments must take into account their effects on the administration of all other nutrient components of this drug. 1. Adults Recommended daily dose - 0.16 g-0.35 g of nitrogen per kg of body weight (1 g-2 g of amino acids per kg of body weight), depending on the patient's nutritional status and degree of catabolism - 20-40 kcal per kg of body weight as total calories - 20-40 mL per kg of body weight as the total volume administered, or 1-1.5 mL per kcal consumed Maximum daily dose - The maximum daily dose is 35 mL per kg of body weight (equivalent to 2.0 g of amino acids, 3.9 g of glucose, 1.4 g of fat, 1.2 mmol of sodium, and 1.1 mmol of potassium per kg of body weight) Infusion rate - The infusion rate should not exceed 1.8 mL/kg per hour (equivalent to 0.10 g/kg of amino acids, 0.19 g/kg of glucose, and 0.07 g/kg of fat per hour). 3. Method and duration of administration - Because of its high osmolarity, this drug should be infused only into a central vein. The recommended infusion duration is 12~24 hours. Intravenous nutrition may be continued as needed according to the patient's condition. - In general, gradually increase the infusion rate over the first hour after starting administration, adjusting it in consideration of the total volume, daily dose, and infusion time.

Child administration

2. Pediatric patients aged 2 years and older - Daily requirements for dosage, nitrogen, and calories decrease with increasing age. - In patients aged 2 to 11 years, the limiting factor for the daily dose is the magnesium concentration, and the limiting factor for the hourly rate is the glucose concentration. - In patients aged 12 to 18 years, the limiting factors for the daily dose are the amino acid and magnesium concentrations, and the limiting factor for the hourly rate is the amino acid concentration. - Usually, lower doses are started in young children and gradually increased to the maximum dose. 1) Pediatric patients aged 2 to 11 years Maximum daily dose - The maximum daily dose is 25 mL/kg body weight (equivalent to 1.4 g amino acids/kg body weight, 2.8 g glucose/kg body weight, 1.0 g fat/kg body weight, and a total of 26.8 kcal/kg body weight) Infusion rate - The infusion rate should not exceed 3.3 mL/kg/hour (equivalent to 0.19 g amino acids/kg/hour, 0.36 g glucose/kg/hour, and 0.13 g fat/kg/hour) 2) Pediatric patients aged 12 to 18 years Maximum daily dose - The maximum daily dose is 35 mL/kg body weight (equivalent to 2.0 g amino acids/kg body weight, 3.9 g glucose/kg body weight, 1.4 g fat/kg body weight, and a total of 37.5 kcal/kg body weight) Infusion rate - The infusion rate should not exceed 2.1 mL/kg/hour (equivalent to 0.12 g amino acids/kg/hour, 0.23 g glucose/kg/hour, and 0.08 g fat/kg/hour)

Precautions

This medication must be used according to the physician's instructions, and it should not be used arbitrarily based on personal judgment. If signs of anaphylactic reactions such as fever, chills, rash, or difficulty breathing occur during administration of this medication, stop administration immediately and consult a medical professional. When mixed with intravenous calcium-containing preparations and Ceftriaxone, there is a risk of the formation of Ceftriaxone-calcium precipitate, so this medication and calcium-containing preparations should not be administered with the same infusion device simultaneously. Premature infants and low birth weight infants have low lipid metabolism capability, so caution is especially needed when administering the lipid components of this medication as they may accumulate in the body. This medication should not be administered to certain patients such as premature infants, newborns, children under 2 years old, patients with specific allergies, severe renal impairment, or liver disease, as its use is prohibited in these populations. Patients with renal failure, diabetes, liver dysfunction, heart failure, and other diseases affecting lipid metabolism must use this medication more cautiously, and it is important to improve their condition prior to administration. Excessive administration or too rapid infusion rates of this medication can cause side effects, hence proper dosage and rates must be adhered to. During the initial administration period, abnormal symptoms such as sweating, fever, chills, headache, rash, and difficulty breathing may occur, so if these symptoms arise, administration should be stopped immediately. While undergoing treatment, it is essential to regularly monitor fluid and electrolyte balance, blood glucose, liver and kidney function, and blood lipid levels, and prompt action must be taken if any abnormalities are detected. This medication must be administered via a central vein and if there is extravasation during infusion, it must be stopped immediately, and appropriate measures should be taken. The safety for pregnant and breastfeeding women has not been established, so this medication should only be administered when the therapeutic benefits outweigh the risks. In pediatric patients, it may only be administered to those aged 2 years and older, and pediatric vitamins and trace elements must be supplemented during administration. This medication poses a risk of precipitate formation when mixed or co-administered with other drugs, and must be mixed and administered following the expert's directions. In cases of overdose, symptoms may include acidosis, fluid overload, and hyperglycemia, and in severe cases, treatments such as blood dialysis may be needed. During the use of this medication, it is crucial to ensure catheter management and aseptic techniques to prevent infection, and if signs of infection arise, it should be reported to a medical professional immediately. After administration of this medication, it may affect certain clinical test results, so it is advisable to consult with medical professionals about the timing and method of tests.

Side effects

fever, chills, rash, dyspnea, sweating, headache, skin rash (erythematous, papular, pustular, macular, generalized rash), pruritus, flushing, tachycardia, appetite loss, hypertriglyceridemia, abdominal pain, diarrhea, nausea, vomiting, hypertension, pain, irritation, swelling/edema, erythema/warmth, skin necrosis, vesicles/blisters, inflammation, sclerosis, skin tightness, lipodystrophy, hepatic steatosis, hepatomegaly, splenomegaly, liver function decline, anemia, leukopenia, thrombocytopenia, blood coagulation abnormalities, coma, thrombocytopenia, cholestasis, hepatomegaly, jaundice, hypersensitivity reaction, liver disease related to intravenous nutrition, increased alkaline phosphatase in the blood, increased transaminases, increased bilirubin in the blood, elevated liver enzymes, azotemia, pulmonary vascular embolism, pulmonary vascular deposits, pulmonary vascular embolism, extravascular leakage, pain, irritation, swelling/edema, erythema/warmth, skin necrosis, vesicles/blisters, inflammation, sclerosis, skin tightness, vomiting, nausea, chills, headache, warmth, sweating, electrolyte disturbances, hyperglycemia, glycosuria, hyperosmolar syndrome, pulmonary vascular embolism, dyspnea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress. The storage temperature should be maintained at room temperature, ensuring that the medication does not freeze.

Appearance and packaging

Appearance

A transparent plastic bag divided into three compartments by two membranes, where the amino acid solution and sugar solution are clear, colorless to pale yellow liquids, and the fat solution is a homogeneous milky liquid.

Package unit

1000ml (400ml amino acid solution, 400ml sugar solution, 200ml fat solution), 1500ml (600ml amino acid solution, 600ml sugar solution, 300ml fat solution), 2000ml (800ml amino acid solution, 800ml sugar solution, 400ml fat solution)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.